Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q1 2026 · 10-Q
Revenue$59.54M$59.54M+2.4% vs Q1 2025 Net Income$4.74M$4.74M+40.0% vs Q1 2025 EPS Diluted$0.85$0.85+37.1% vs Q1 2025 Gross Profit$36,939,000−0.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flow$1,893,000−82.4% Free Cash Flowderived$884,000−91.0% Margins · derivedGross margin62.0%−2.0 pt vs Q1 2025
Operating margin5.1%−4.4 pt vs Q1 2025
Net margin8.0%+2.1 pt vs Q1 2025
ended Jun 30, 2025 · filed Aug 5, 2025 · 36 d after period end